Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InspireMD (NSPR) Other Operating Expenses (2016 - 2025)

InspireMD filings provide 16 years of Other Operating Expenses readings, the most recent being $3.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 366.82% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.3 million, a 578.51% increase, with the full-year FY2025 number at $10.2 million, up 611.2% from a year prior.
  • Other Operating Expenses hit $3.9 million in Q4 2025 for InspireMD, up from $2.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $3.9 million in Q4 2025 to a low of $92000.0 in Q1 2024.
  • Median Other Operating Expenses over the past 5 years was $844500.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other Operating Expenses: plummeted 88.32% in 2024 and later surged 1271.74% in 2025.
  • InspireMD's Other Operating Expenses stood at $761000.0 in 2021, then soared by 42.84% to $1.1 million in 2022, then grew by 20.42% to $1.3 million in 2023, then plummeted by 35.52% to $844000.0 in 2024, then skyrocketed by 366.82% to $3.9 million in 2025.
  • The last three reported values for Other Operating Expenses were $3.9 million (Q4 2025), $2.6 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.